What happens in brain cells affected by Alzheimer’s disease?

Must read

Sleep Paralysis: Demon in the Bedroom

The woman was in her late 50s. Every night she would fall asleep and then dream that she was unable to move, but that...

US Hitting Encouraging Milestones on Virus Deaths and Shots

Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. ...

Vaccine Mandates Aren’t The Only – Or Easiest – Way For Employers To Compel Workers To Get Their Shots

A workplace showdown may be brewing over mandating vaccinations.Employers would love the sense of certainty that comes with a vaccinated workforce. Workers can be...

brain
Credit: Unsplash/CC0 Public Domain

Affecting over 50 million people, Alzheimer’s disease is the most common form of dementia and primarily occurs in people over the age of 65. The pathology of the disease in the brain is mainly characterized by two factors: beta-amyloid plaques outside the nerve cells and tau proteins. The tau protein stabilizes tube-like structures (microtubules) inside cells, which are relevant for the transport of nutrients in nerve cells. Beta-amyloid is a protein present in the body that is formed by the cleavage of the amyloid precursor protein (APP).

APP is embedded in the cell membrane of the and protrudes both on the inside and outside. Typically, it is cleaved once near the cell membrane The part inside the nerve cells is unstable and disintegrates. In Alzheimer’s patients, two cleavages take place, resulting in the formation of three parts. The new findings now indicate that the part inside the nerve cells is more stable in Alzheimer’s patients. It consists of only approximately 50 and can, under certain conditions, migrate into the together with other proteins such as FE65 and TIP60. This , also known as nuclear aggregates, has the capacity to manipulate the cell’s gene expression. “This suggests that the aggregates have a function in this region,” points out lead author David Marks from the Cell Signaling group at RUB. Closer analysis confirmed this evidence, as a protein was found within the nuclear aggregates that is involved in the modification of DNA.

Two more protein candidates in cells

“To understand this mechanism even better, we looked for other proteins that might be part of these aggregates and identified two more candidates involved in the nuclear aggregates, the so-called tumor suppressor proteins P53 and PML,” explains David Marks. The study team showed in experiments on living cells that nuclear aggregates formed from the proteins APP-CT50, FE65, TIP60 and PML fuse with each other over time and produce even larger nuclear aggregates.

In addition, they examined brain samples from older deceased persons as well as self-generated neuronal tissue from induced pluripotent stem cells. “These mini-brains, so-called , reflect the embryonic and developmental phase of a brain fairly accurately,” explains Thorsten Müller. The research team found nearly no nuclear aggregates in the comparatively young cerebral organoids, whereas they were present in brain samples from older patients. “This leads us to conclude that the process depends on age,” says Müller.

Striking correlation

Furthermore, the researchers showed on these brain samples that APP-CT50 and FE65 can make up part of the so-called PML bodies, which occur naturally in large numbers of cell nuclei. Upon further analysis of hippocampal brain slices from Alzheimer’s patients, the authors identified a significant correlation between a reduced number of PML bodies in the nucleus in regions with a high beta-amyloid plaque load. In particular, such regions mean that there is higher expression and processing of APP. This may suggest that the transfer of APP-CT50 and FE65 into the nucleus is part of AD pathology and affects the fusion of PML bodies there.


Nanoparticles help untangle Alzheimer’s disease amyloid beta plaques


More information:
David Marks et al, Amyloid precursor protein elevates fusion of promyelocytic leukemia nuclear bodies in human hippocampal areas with high plaque load, Acta Neuropathologica Communications (2021). DOI: 10.1186/s40478-021-01174-x

Citation:
What happens in brain cells affected by Alzheimer’s disease? (2021, June 11)
retrieved 11 June 2021
from https://medicalxpress.com/news/2021-06-brain-cells-affected-alzheimer-disease.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.

- Advertisement -

More articles

- Advertisement -

Latest article

Sleep Paralysis: Demon in the Bedroom

The woman was in her late 50s. Every night she would fall asleep and then dream that she was unable to move, but that...

US Hitting Encouraging Milestones on Virus Deaths and Shots

Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. ...

Vaccine Mandates Aren’t The Only – Or Easiest – Way For Employers To Compel Workers To Get Their Shots

A workplace showdown may be brewing over mandating vaccinations.Employers would love the sense of certainty that comes with a vaccinated workforce. Workers can be...

Survey Highlights Unequal U.S. Health Care System

June 21, 2021 -- Keeva Blackwood, Deidra Fryer, and Tricia...